LawPlayer
My bookmarks
Source

Commission Implementing Regulation (EU) 2023/216 of 1 February 2023 approving the low-risk active substance Trichoderma atroviride AGR2 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance)

Commission Implementing Regulation (EU) 2023/216 of 1 February 2023 approving the low-risk active substance Trichoderma atroviride AGR2 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance)

Implementing Regulation (EU) 2023/216 · Regulation · 5 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Approval of the active substance

Article 1

Open ↗

The active substance Trichoderma atroviride AGR2, as specified in Annex I, is approved subject to the conditions laid down in that Annex.

Amendments to Implementing Regulation (EU) No 540/2011

Article 2

Open ↗

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with Annex II to this Regulation.

Entry into force

Article 3

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEX ISupplementary provisions

Open ↗

ANNEX I Common Name, Identification Numbers IUPAC Name Purity  ( 1 ) Date of approval Expiration of approval Specific provisions Trichoderma atroviride AGR2 n.a. The nominal content of Trichoderma atroviride AGR2 in the technical product and formulation is Minimal: 5 x 10 11 CFU/kg Nominal: 1 x 10 12 CFU/kg Maximal: 1 x 10 13 CFU/kg No relevant impurities 22 February 2023 21 February 2038 For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on Trichoderma atroviride AGR2 and in particular Appendices I and II thereof, shall be taken into account. In this overall assessment, Member States shall pay particular attention to: — the specification of the technical material as commercially manufactured used in plant protection products, including full characterisation of relevant secondary metabolites; — the protection of operators and workers, taking into account that microorganisms are per se considered as potential sensitizers. Use of PPE/RPE might be recommended to reduce dermal and inhalation exposure. ( 1 )   Further details on the identity and the specification of the active substance are provided in the review report.

ANNEX IISupplementary provisions

Open ↗

ANNEX II In Part D of the Annex to Implementing Regulation (EU) No 540/2011, the following entry is added: No. Common Name, Identification Numbers IUPAC Name Purity  ( 1 ) Date of approval Expiration of approval Specific provisions ‘42 Trichoderma atroviride AGR2 n.a. The nominal content of Trichoderma atroviride AGR2 in the technical product and formulation is Minimal: 5 x 10 11 CFU/kg Nominal: 1 x 10 12 CFU/kg Maximal: 1 x 10 13 CFU/kg No relevant impurities 22 February 2023 21 February 2038 For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on Trichoderma atroviride AGR2 and in particular Appendices I and II thereof, shall be taken into account. In this overall assessment Member States shall pay particular attention to: — the specification of the technical material as commercially manufactured used in plant protection products, including full characterisation of relevant secondary metabolites; — the protection of operators and workers, taking into account that microorganisms are per se considered as potential sensitizers. Use of PPE/RPE might be recommended to reduce dermal and inhalation exposure.’ ( 1 )   Further details on the identity and the specification of the active substance are provided in the review report.

Other acts of the same type
Commission Delegated Regulation (EU) 2023/503 of 1 December 2022 amending Regulation (EU) 2017/746 of the European Parliament and of the Council as regards the frequency of complete re-assessments of notified bodies (Text with EEA relevance)Commission Regulation (EU) 2022/2340 of 30 November 2022 amending Annex III to Regulation (EC) No 1925/2006 of the European Parliament and of the Council as regards green tea extracts containing (-)-epigallocatechin-3-gallate (Text with EEA relevance)Commission Implementing Regulation (EU) 2022/2334 of 29 November 2022 amending Implementing Regulation (EU) 2015/2447 as regards the application of monitoring of decisions relating to binding information and introducing a flexibility in the procedures for issuing of or making out proofs of originCommission Implementing Regulation (EU) 2022/2344 of 29 November 2022 on the reimbursement, in accordance with Article 17(3) of Regulation (EU) 2021/2116 of the European Parliament and of the Council, of the appropriations carried over from financial year 2022Commission Implementing Regulation (EU) 2022/2375 of 29 November 2022 approving Union amendments to the specification for a Protected Designation of Origin or a Protected Geographical Indication (‘Bianco di Custoza’/‘Custoza’ (PDO))Commission Delegated Regulation (EU) 2023/369 of 29 November 2022 correcting the Polish language version of Regulation (EU) No 139/2014 laying down requirements and administrative procedures related to aerodromes pursuant to Regulation (EC) No 216/2008 of the European Parliament and of the Council (Text with EEA relevance)Commission Implementing Regulation (EU) 2022/2329 of 28 November 2022 amending Annex IV to Implementing Regulation (EU) 2021/404 as regards the entries for Egypt and Türkiye in the list of third countries, territories or zones thereof authorised for the entry into the Union of consignments of certain equine animals (Text with EEA relevance)Commission Implementing Regulation (EU) 2022/2330 of 28 November 2022 granting a Union authorisation for the single biocidal product 'Christiansen LD Bednet' in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (Text with EEA relevance)Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)Council Regulation (EU) 2022/2309 of 25 November 2022 concerning restrictive measures in view of the situation in HaitiCommission Implementing Regulation (EU) 2022/2312 of 25 November 2022 on eight-yearly variables in the labour force domain on ‘young people on the labour market’, ‘educational attainment – details, including education interrupted or abandoned’ and ‘reconciliation of work and family life’ pursuant to Regulation (EU) 2019/1700 of the European Parliament and of the Council (Text with EEA relevance)Commission Implementing Regulation (EU) 2022/2313 of 25 November 2022 entering a name in the register of traditional specialities guaranteed (Pizza Napoletana (TSG))

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next